SCHEMBL11168902

SCHEMBL11168902

CC(=O)Nc1ccc(O)c(-c2ccccc2Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.56
▸ MAPT P10636 3/20 0.56
▸ MAOA P21397 3/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.51
▸ CCNE2 O96020 1/20 0.49
▸ EGFR P00533 1/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CDK4 P11802 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ CCND1 P24385 1/20 0.49
▸ CCNE1 P24864 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ CCNA1 P78396 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16504459 0.85 KDM5A (0.59) RAB9AMAPTMAOASMN1; SMN2MEN1
SCHEMBL31198183 0.79 HSD17B10 (0.59) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL5674663 0.79 HSD17B10 (0.59) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL11163471 0.77 SMN1; SMN2 (0.50) RAB9AMAPTMAOASMN1; SMN2MEN1
SCHEMBL17736353 0.77 NQO2 (0.57) RAB9AMAPTMAOASMN1; SMN2MEN1
SCHEMBL9815484 0.75 PKM (0.59) RAB9AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL29209949 0.74 KDM4E (0.58) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL7547627 0.73 ALDH1A1 (0.59) RAB9AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL3192352 0.73 PKM (0.65) RAB9AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL2611896 0.72 ALB (0.61) RAB9ASMN1; SMN2NPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0027679-B1 SUBSTITUTED-5-((7-CHLORO-4-QUINOLINYL)AMINO)-3-(AMINO-METHYL)-(1,1'-BIPHENYL)-2-OL COMPOUNDS; PROCESSES FOR THEIR PRODUCTION; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1983-08-10 — — EP disclosed
EP-0027679-A2 Substituted-5-((7-chloro-4-quinolinyl)amino)-3-(amino-methyl)-(1,1'-biphenyl)-2-ol compounds; processes for their production; and pharmaceutical compositions containing the compounds WARNER-LAMBERT COMPANY (US) 1981-04-29 — — EP disclosed
Send feedback